CERo Therapeutics Holdings, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2023 | — | $-42.1M | $96.9K |
| FY2024 | — | $-2.3M | $3.3M |
| FY2025 | — | $-5.4M | $1.7M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2023 | — | $-42.1M | $96.9K |
| FY2024 | — | $-2.3M | $3.3M |
| FY2025 | — | $-5.4M | $1.7M |